Yearly Archives: 2026
Halia Therapeutics Secures FDA Fast Track for Ofirnoflast
The designation follows encouraging Phase 2 clinical trial results.
Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million
Proceeds from transaction to support advancement of Denali’s broad TransportVehicle™-enabled clinical portfolio for lysosomal storage disorders and neurodegenerative diseases.
Co-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated Manufacturing Line
Visit has included tour of Utah headquarters and automated manufacturing facilities ahead of planned technology transfer.
CancerVax Successfully Demonstrates Full Nanoparticle Delivery in Mouse Study
First biodistribution study of the Company’s complete cancer targeting nanoparticle avoided many healthy organs.
nCAP Medical Announces Publication of Positive RCT Results Demonstrating NeuroCuple® Provides Meaningful, Opioid-Sparing Pain Relief Immediately Following Total Knee Arthroplasty
The study, published in the Journal of Arthroplasty, highlighted that the Company’s NeuroCuple® Nanotechnology Device achieved statistically significant reduction in opioid use.
HITLAB World Cup Innovation Hackathon
Build It Live at the HITLAB World Cup.
DiscGenics Announces Independent DSMB Safety Review Supports Continuation of Phase III Study of IDCT Without Modifications
The DSMB review was conducted as part of the pre-planned clinical safety oversight process agreed upon with the U.S. FDA.
GlobalMed Logistix to Open Western U.S. Hub in Salt Lake City, Establishing Bi-Coastal Logistics Network Purpose-Built for Medtech
New 75,000-square-foot facility to open in October 2026 near Salt Lake City International Airport, extending company’s national reach for medical device manufacturers
Seek Labs Maps 25/25 Viral Families through BioSeeker, Advancing a New Model for Sequence-Directed Antiviral Discovery
The company’s comprehensive viral target atlas is designed to move development from reactive crisis response toward proactive, pre-identified genomic vulnerability mapping
nView Medical Surpasses 1,000 Surgeries
nView medical announced that its nView s1 system has surpassed 1,000 surgeries, marking an important milestone in the clinical use of the company’s intraoperative 3D imaging and navigation technology.
NanoKar Therapeutics Receives Funding From the University of Utah Launchpad Seed Fund to Advance Next-Generation CAR-T Cell Therapy Platform
University of Utah Launchpad Seed Fund award to support translational validation of NanoKar’s ITAM optimization platform, including CAR-T persistence and activity in solid tumor models.
Ratio Therapeutics and PharmaLogic Expand Manufacturing Collaboration to Support Clinical Development of [Ac-225]RTX-2358
Expanded collaboration adds manufacturing capacity, strengthens redundancy, and supports later-stage development planning for Ratio’s lead FAP-targeted radiotherapeutic candidate.
